Comparison between watchful waiting strategy and early initiation of renal replacement therapy in the critically ill acute kidney injury population: an updated systematic review and meta-analysis - 08/01/26

Doi : 10.1186/s13613-020-0641-5 
Jia-Jin Chen 1, Cheng-Chia Lee 1, 2, George Kuo 1, Pei-Chun Fan 1, 2, Chan-Yu Lin 1, 2, Su-Wei Chang 3, Ya-Chung Tian 1, 2, Yung-Chang Chen 4, Chih-Hsiang Chang 1, 2
1 Department of Nephrology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan 
2 Department of Nephrology, Kidney Research Center, Linkou Chang Gung Memorial Hospital, No 5 Fu-shin Street, 333, Taoyuan, Taiwan 
3 Clinical Informatics and Medical Statistics Research Center, College of Medicine, Chang Gung University, Taoyuan, Taiwan 
4 Division of Critical Care Nephrology, Department of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan 

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

The optimal timing of renal replacement therapy (RRT) initiation is debatable. Many articles in this field enrolled trials not based on acute kidney injury. The safety of the watchful waiting strategy has not been fully discussed, and late RRT initiation criteria vary across studies. The effect of early RRT initiation in the AKI population with high plasma neutrophil gelatinase-associated lipocalin (NGAL) has not been examined yet.

Methods

In accordance with PRISMA guidelines, the PubMed, Embase, and Cochrane databases were systemically searched for randomized controlled trials (RCTs). Trials not conducted in the AKI population were excluded. Data of study characteristics, primary outcome (all-cause mortality), and related secondary outcomes [mechanical ventilation (MV) days, length of hospital stay, RRT days, and length of ICU stay] were extracted. The outcomes were compared between early and late RRT groups by estimating the pooled odds ratio (OR) for binary outcomes and the weighted mean difference for continuous outcomes. Prospective trials were also examined and analyzed using the same method.

Results

Nine RCTs with 1938 patients were included. Early RRT did not provide a survival benefit (pooled OR, 0.88; 95% confidence interval [CI] 0.62–1.27). However, the early RRT group had significantly fewer MV days (pooled mean difference, − 3.98 days; 95% CI − 7.81 to − 0.15 days). Subgroup analysis showed that RCTs enrolling the surgical population ( P  = .001) and the AKI population with high plasma NGAL ( P  = .031) had favorable outcomes regarding RRT days in the early initiation group. Moreover, 6 of 9 RCTs were selected for examining the safety of the watchful waiting strategy, and no significant differences were found in primary and secondary outcomes between the early and late RRT groups.

Conclusions

Overall, early RRT initiation did not provide a survival benefit, but a possible benefit of fewer MV days was detected. Early RRT might also provide the benefit of shorter MV or RRT support in the surgical population and in AKI patients with high plasma NGAL. Depending on the conventional indication for RRT initiation, the watchful waiting strategy is safe on the basis of all primary and secondary outcomes.

Le texte complet de cet article est disponible en PDF.

Keywords : Renal replacement therapy, Timing, Acute kidney injury, Watchful waiting strategy

Keywords : Medical and Health Sciences, Clinical Sciences


Plan


© 2020  The Author(s) 2020. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 10 - N° 1

Article 30- 2020 Retour au numéro
Article précédent Article précédent
  • Post-resuscitation shock: recent advances in pathophysiology and treatment
  • Mathieu Jozwiak, Wulfran Bougouin, Guillaume Geri, David Grimaldi, Alain Cariou
| Article suivant Article suivant
  • Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study
  • Mercedes Ibarz, Ariane Boumendil, Lenneke E.M. Haas, Marian Irazabal, Hans Flaatten, Dylan W. de Lange, Alessandro Morandi, Finn H. Andersen, Guido Bertolini, Maurizio Cecconi, Steffen Christensen, Loredana Faraldi, Jesper Fjølner, Christian Jung, Brian Marsh, Rui Moreno, Sandra Oeyen, Christina Agwald Öhman, Bernardo Bollen Pinto, Ivo W. Soliman, Wojciech Szczeklik, Andreas Valentin, Ximena Watson, Tilemachos Zaferidis, Bertrand Guidet, Antonio Artigas, the VIP1 study, René Schmutz, Franz Wimmer, Philipp Eller, Michael Joannidis, Pieter De Buysscher, Nikolaas De Neve, Sandra Oeyen, Walter Swinnen, Bernardo Bollen Pinto, Paul Abraham, Leila Hergafi, Joerg C. Schefold, Ewelina Biskup, Petr Piza, Ioannis Taliadoros, Jesper Fjølner, Nilanjan Dey, Christoffer Sølling, Bodil Steen Rasmussen, Steffen Christensen, Xavier Forceville, Guillaume Besch, Herve Mentec, Philippe Michel, Philippe Mateu, Philippe Michel, Lucie Vettoretti, Jeremy Bourenne, Nathalie Marin, Max Guillot, Nadia Aissaoui, Cyril Goulenok, Nathalie Thieulot-Rolin, Jonathan Messika, Lionel Lamhaut, Bertrand Guidet, Cyril Charron, Alexander Lauten, Anna Lena Sacher, Thorsten Brenner, Marcus Franz, Frank Bloos, Henning Ebelt, Stefan J. Schaller, Kristina Fuest, Christian Rabe, Thorben Dieck, Stephan Steiner, Tobias Graf, Amir M. Nia, Christian Jung, Rolf Alexander Janosi, Patrick Meybohm, Philipp Simon, Stefan Utzolino, Tim Rahmel, Eberhard Barth, Christian Jung, Michael Schuster, Zoi Aidoni, Stavros Aloizos, Polychronis Tasioudis, Kleri Lampiri, Vasiliki Zisopoulou, Ifigenia Ravani, Evmorfia Pagaki, Angela Antoniou, Theodoros A. Katsoulas, Aikaterini Kounougeri, George Marinakis, Fotios Tsimpoukas, Anastasia Spyropoulou, Paris Zygoulis, Aikaterini Kyparissi, Manish Gupta, Mohan Gurjar, Ismail M. Maji, Ivan Hayes, Brian Marsh, Yvelynne Kelly, Andrew Westbrook, Gerry Fitzpatrick, Darshana Maheshwari, Catherine Motherway, Giovanni Negri, Savino Spadaro, Guisepepe Nattino, Matteo Pedeferri, Annalisa Boscolo, Simona Rossi, Giuseppe Calicchio, Lucia Cubattoli, Gabriella Di Lascio, Maria Barbagallo, Francesco Berruto, Daniela Codazzi, Andrea Bottazzi, Paolo Fumagalli, Giancarlo Negro, Giuseppe Lupi, Flavia Savelli, Giuseppe A. Vulcano, Roberto Fumagalli, Andrea Marudi, Ugo Lefons, Rita Lembo, Maria Babini, Alessandra Paggioro, Vieri Parrini, Maria Zaccaria, Stefano Clementi, Carmelo Gigliuto, Francesca Facondini, Simonetta Pastorini, Susanna Munaron, Italo Calamai, Anna Bocchi, Adele Adorni, Maria Grazia Bocci, Andrea Cortegiani, Tariana Casalicchio, Serena Melia, Elia Graziani, Massimo Barattini, Elisabetta Brizio, Maurizio Rossi, Michael Hahn, Hans Flattens, Nicolai Kemmerer, Hans Frank Streiter, Knut Dybwik, Terje Legernaes, Pål Klepstad, Even Braut Olaussen, Knut Inge Olsen, Ole Marius Brresen, Geir Bjorsvik, Finn H. Andersen, Sameer Maini, Lutz Fehrle, Mirosław Czuczwar, Paweł Krawczyk, Mirosław Ziętkiewicz, Łukasz R. Nowak, Katarzyna Kotfis, Katarzyna Cwyl, Ryszard Gajdosz, Jowita Biernawska, Romuald Bohatyrewicz, Ryszard Gawda, Paweł Grudzień, Paweł Nasiłowski, Natalia Popek, Waldemar Cyrankiewicz, Katarzyna Wawrzyniak, Marek Wnuk, Dariusz Maciejewski, Dorota Studzińska, Maciej Żukowski, Szymon Bernas, Mariusz Piechota, Wojciech Szczeklik, Ilona Nowak-Kózka, Jakub Fronczek, Marta Serwa, Waldemar Machała, Jan Stefaniak, Maria Wujtewicz, Małgorzata Szymkowiak, Barbara Adamik, Kamil Polok, Anna Włudarczyk, Jacek Górka, Natalia Kozera, Waldemar Goździk, Nuno Catorze, Miguel Castelo Branco, Inês Barros, Nelson Barros, Andriy Krystopchuk, Teresa Honrado, Cristina Sousa, Francisco Munoz, Marta Rebelo, Rui Gomes, Jorge Nunes, Celeste Dias, Ana Margarida Fernandes, Cristina Petrisor, Bodolea Constantin, Vladislav Belskiy, Boris Boskholov, Enver Rodriguez, Sergio Rebollo, Gerardo Aguilar, Gaspar Masdeu, Marián Irazábal Jaimes, Ángela Prado Mira, Maria A. Bodi, Jesus A. Barea Mendoza, Sonia López-Cuenca, Marcela Homez Guzman, Jesús Rico-Feijoo, Mercedes Ibarz, Josep Trenado Alvarez, Rafael Kawati, Joakim Sivik, Jessica Nauska, Daniel Smole, Fredric Parenmark, Johanna Lyrén, Katalin Rockstrohm, Sara Rydén, Martin Spångfors, Morten Strinnholm, Sten Walther, Lina De Geer, Peter Nordlund, Staffan Pålsson, Harald Zetterquist, Annika Nilsson, Karin Thiringer, Mårten Jungner, Björn Bark, Berit Nordling, Hans Sköld, Camilla Brorsson, Stefan Persson, Anna Bergström, Johan Berkius, Johanna Holmström, I. van Dijk, Lenneke E.M. Haas, D. Ramnarain, Tim Jansen, Fleur Nooteboom, Peter H.J. van der Voort, Dylan de Lange, Willem Dieperink, Monique C. de Waard, Annemarie G.E. de Smet, Laura Bormans, Tom Dormans, Ged Dempsey, Shiju J. Mathew, Ashok S. Raj, Irina Grecu, Jason Cupitt, Tom Lawton, Richard Clark, Monica Popescu, Nick Spittle, Maria Faulkner, Amanda Cowton, Esme Elloway, Patricia Williams, Michael Reay, Srikanth Chukkambotla, Ravi Kumar, Nawaf Al-Subaie, Linda Kent, Tiina Tamm, Istvan Kajtor, Karen Burns, Richard Pugh, Marlies Ostermann, Elisa Kam, Helen Bowyer, Neil Smith, Maie Templeton, Jeremy Henning, Kelly Goffin, Ritoo Kapoor, Shondipon Laha, Phil Chilton, Waqas Khaliq, Alison Crayford, Samantha Coetzee, Moira Tait, Wendy Stoker, Marc Gimenez, Alan Pope, Julie Camsooksai, David Pogson, Kate Quigley, Jenny Ritzema, Anil Hormis, Carole Boulanger, M. Balasubramaniam, Luke Vamplew, Karen Burt, Daniel Martin, Irina Grecu, Jayne Craig, John Prowle, Nanci Doyle, Jonathon Shelton, Carmen Scott, Phil Donnison, Sarah Shelton, Christian Frey, Christine Ryan, Dominic Spray, Christine Ryan, Veronica Barnes, Kerry Barnes, Stephanie Ridgway, Rajnish Saha, Linda Kent, Thomas Clark, James Wood, Clare Bolger, Christopher Bassford, Amanda Cowton, John Lewandowski, Xiaobei Zhao, Sally Humphreys, Susan Dowling, Neil Richardson, Andrew Burtenshaw, Carl Stevenson, Danielle Wilcock, Yuiry Nalapko

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.